Cargando…

P763: EFFICACY AND SAFETY OF AVATROMBOPAG IN THE TREATMENT OF TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA

Detalles Bibliográficos
Autores principales:	Zhang, Ting, He, Guangsheng, Shi, Jinning, Gong, Yuemin, Zhang, Yawen, Long, Qiqiang, LI, Jianyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429197/ http://dx.doi.org/10.1097/01.HS9.0000969956.74779.bf

Ejemplares similares

Transfusion-dependent non-severe aplastic anemia: characteristics and outcomes in the clinic
por: Zhang, Yawen, et al.
Publicado: (2023)

Efficacy and safety of avatrombopag in aplastic anemia patients with liver disease
por: Wang, Huaquan, et al.
Publicado: (2023)

PB2048: HEMATOLOGIC RECOVERY INDUCED BY AVATROMBOPAG IN SAA REFRACTORY OR INTOLERANT TO IMMUNOSUPPRESSIVE THERAPY COMBINED WITH ELTROMBOPAG
por: Liu, Xiaoqing, et al.
Publicado: (2023)

PB2049: THE EFFICACY OF HETROMBOPAG PLUS CYCLOSPORINE A IN PATIENTS WITH TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA: A PROSPECTIVE REGISTRY STUDY
por: Gong, Yuemin, et al.
Publicado: (2023)

P773: CYCLOPHOSPHAMIDE COMBINED WITH PREDNISONE FOR CYCLOSPORINE-REFRACTORY/RELAPSED T-LARGE GRANULAR LYMPHOCYTE LEUKEMIA ASSOCIATED PURE RED CELL APLASIA
por: Liu, Xiaoqing, et al.
Publicado: (2023)

Comparison of eltrombopag and avatrombopag in the treatment of refractory/relapsed aplastic anemia: a single-center retrospective study in China
por: Zhang, Zhuxin, et al.
Publicado: (2023)

Predicting Response of Severe Aplastic Anemia to Rabbit-Antithymocyte Immunoglobulin Based Immunosuppressive Therapy Combined With Eltrombopag
por: Li, Ruixin, et al.
Publicado: (2022)

PB2041: COMPARISON OF ELTROMBOPAG AND AVATROMBOPAG IN THE TREATMENT OF REFRACTORY/RELAPSED APLASTIC ANEMIA, A SINGLE CENTER STUDY IN CHINA
por: Zhang, Zhuxin, et al.
Publicado: (2023)

PB2479: ELTROMBOPAG, BUT NOT AVATROMBOPAG, REGULATES BONE MARROW MICROENVIRONMENT MIMICKING APLASTIC ANEMIA THROUGH DOWN-REGULATION OF FERROPTOSIS INHIBITOR
por: Ji, Jiang, et al.
Publicado: (2023)

P793: EFFICACY AND IN VIVO EFFECTS OF PORCINE ANTIHUMAN LYMPHOCYTE IMMUNOGLOBULIN COMPARED TO RABBIT ANTITHYMOCYTE IMMUNOGLOBULIN IN SEVERE APLASTIC ANEMIA
por: He, Guangsheng, et al.
Publicado: (2023)

Efficacy and safety of eltrombopag in Chinese patients with refractory or relapsed severe aplastic anemia
por: Chang, Hong, et al.
Publicado: (2023)

P1310: HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HEPATITIS‑ASSOCIATED APLASTIC ANEMIA AND NON‑HEPATITIS‑ASSOCIATED APLASTIC ANEMIA: A PROPENSITY SCORE-MATCHED ANALYSIS
por: LI, Jia
Publicado: (2023)

PB2034: TARGETED SEQUENCING LANDSCAPE OF A CHINESE PURE RED CELL ANEMIA COHORT
por: LI, Yue, et al.
Publicado: (2023)

P819: TRANSPLANT, TREATMENT AND TRANSFUSION FREE (TTT-FREE) SURVIVAL AS RELEVANT CLINICAL ENDPOINT AFTER IMMUNOSUPPRESSIVE TREATMENT FOR ACQUIRED APLASTIC ANEMIA IN ADULTS
por: Koster, E., et al.
Publicado: (2022)

P807: APLASTIC ANEMIA FOLLOWING THE SARS-COV-2 VACCINE
por: Babakhanlou, R., et al.
Publicado: (2022)

P1335: REPAIR OF DYSFUNCTIONAL BONE MARROW ENDOTHELIAL CELLS ALLEVIATES APLASTIC ANEMIA
por: Tang, Shu-Qian, et al.
Publicado: (2023)

Avatrombopag, a promising novel thrombopoietin receptor agonist for refractory/relapsed/intolerant non-severe aplastic anemia: a phase 2 single-arm clinical trial
por: Wan, Ziqi, et al.
Publicado: (2023)

PB2067: PROSPECTIVE SELF-CONTROL ANALYSIS OF GLUCOCORTICOID MAINTENANCE THERAPY FOR PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
por: Yang, Hui, et al.
Publicado: (2023)

P1611: EFFICACY AND SAFETY OF AVATROMBOPAG FOR THE TREATMENT OF CHRONIC IMMUNE THROMBOCYTOPENIA IN A CHINESE ADULT POPULATION：A MULTICENTER, RANDOMIZED PHASE III TRIAL
por: Mei, Heng, et al.
Publicado: (2023)

Aplastic Anemia in China
por: Liu, Chunyan, et al.
Publicado: (2018)

763. Correlates of Antiretroviral Therapy Initiation Among Newly Diagnosed Older People with HIV in Ukraine
por: Allen, Amy J, et al.
Publicado: (2020)

Avatrombopag: A Review in Thrombocytopenia
por: Markham, Anthony
Publicado: (2021)

P792: CLINICAL STUDY OF HETROMBOPAG COMBINED WITH CYCLOSPORINE A IN THE TREATMENT OF CHILDREN WITH NON-SEVERE APLASTIC ANEMIA
por: Chang, Lixian, et al.
Publicado: (2023)

P796: ENRICHED CD16+ MONOCYTES DRIVE T LYMPHOCYTES CELL RESPONSES IN APLASTIC ANEMIA
por: Ge, M., et al.
Publicado: (2022)

P794: EVALUATION OF PEGCETACOPLAN IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS WITH APLASTIC ANEMIA IN THE PRINCE STUDY
por: Bogdanovic, Andrija, et al.
Publicado: (2023)

P1308: RUXOLITINIB AS GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS FOR ALLOGENEIC STEM CELL TRANSPLANTATION IN APLASTIC ANEMIA PATIENTS
por: Zhang, Xiaoyu, et al.
Publicado: (2023)

A Case of Late Stent Thrombosis Following Platelet Transfusion in a Patient With Aplastic Anemia
por: Shin, Hyun-Sung, et al.
Publicado: (2012)

Cyclosporine Therapy in Patients with Transfusion-independent Non-severe Aplastic Anemia: A Retrospective Analysis
por: Matsuda, Kensuke, et al.
Publicado: (2018)

P766: ELTROMBOPAG EFFECTIVELY ALLEVIATES APLASTIC ANEMIA THROUGH REDUCING AKT PROTEIN STABILITY AND MODULATING T LYMPHOCYTE SUBSETS
por: Lin, Zenghua, et al.
Publicado: (2023)

P761: UMBILICAL CORD BLOOD ORIGIN CELLS RECONSTRUCT THE HEMATOPOIESIS OF APLASTIC ANEMIA ANIMAL MODEL
por: Chen, Zesong, et al.
Publicado: (2023)

Idiopathic Aplastic Anemia: An Update
por: Solomou, Elena E.
Publicado: (2019)

Correction to: Avatrombopag: A Review in Thrombocytopenia
por: Markham, Anthony
Publicado: (2021)

Aplastic anemia in the elderly: a nationwide survey on behalf of the French Reference Center for Aplastic Anemia
por: Contejean, Adrien, et al.
Publicado: (2019)

P832: CLINICAL OUTCOMES AND IMMUNE RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH SEVERE APLASTIC ANEMIA
por: Rajput, R., et al.
Publicado: (2022)

P805: ALEMTUZUMAB IN RELAPSED SEVERE APLASTIC ANEMIA: LONG-TERM RESULTS OF A PHASE II STUDY
por: Aggarwal, N., et al.
Publicado: (2022)

P768: PRELIMINARY EXPLORATION ON LAG-3 EXPRESSION OF BONE MARROW-DERIVED MACROPHAGES IN SEVERE APLASTIC ANEMIA
por: Zhong, Congwei, et al.
Publicado: (2023)

P1353: EXPLORING A NOVEL TREATMENT STRATEGY FOR ACQUIRED APLASTIC ANEMIA TARGETING PPAR SIGNALING PATHWAY.
por: Yang, Liping, et al.
Publicado: (2023)

Traditional Chinese medicine for treating aplastic anemia
por: Guan, Jing, et al.
Publicado: (2023)

Value of transfusion independence in severe aplastic anemia from patients’ perspectives – a discrete choice experiment
por: Pickard, A. Simon, et al.
Publicado: (2018)

First case of convalescent plasma transfusion in a child with COVID-19-associated severe aplastic anemia
por: Figlerowicz, Magdalena, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9chfl27spgrpoiq0rfiq1i54po